Hibiocy Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SINGAPORE, Nov. 1, 2022 /PRNewswire/ GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company supported Chulalongkorn University, a research-intensive university in Thailand in developing human anti-SARS-CoV-2 antibodies with antibody production and characterization services. The antibodies were licensed to Hibiocy Co. Ltd., which further developed them into a nasal spray medical device named VAILL COVITRAP. The Thai FDA has approved VAILL COVITRAP as a Class 4 medical device, making Thailand the first country to approve the manufacturing of human monoclonal antibody-based COVID-19 nasal spray. The human anti-SARS-CoV-2 antibodies which area crucial part ofthe VAILL COVITRAP nasal spray device weredeveloped by Dr. Trairak Pisitkun's team from Chulalongkorn University, Bangkok, Thailand. GenScript has supported the team with antibody production and characterization during the early phase of research and contributed to the d ....

Hong Kong , New Jersey , United States , Krung Thep Mahanakhon , Johnson Wang , Trairak Pisitkun , Genscript Asia Pacific , Hibiocy Co , Hong Kong Stock Exchange , Prnewswire Genscript Biotech Corporation , Chulalongkorn University , Genscript Biotech Corporation , Script Biotech Corporation , Stock Code , Genscript Asia , Genscript Biotech , Script Biotech , Mainland China , Cov 1 , 022 Prnewswire Genscript Biotech Corporation Quot , Tock Code 1548 Hk , A Leading Global Biotechnology Company Supported Chulalongkorn University , A Research Intensive University In Thailand Developing Human Anti Sars Cov 2 Antibodies With Antibody Production And Characterization Services The Were Licensed To Hibiocy Co Ltd , Hich Further Developed Them Intoa Nasal Spray Medical Device Named Vaill Covitrap The Thai Fda Has Approved Asa Class 4 , Aking Thailand The First Country To Approve Manufacturing Of Human Monoclonal Antibody Based Covid 19 Nasal Spray Anti Sars Cov 2 Antibodies Which Area Crucial Part Ofthe Vaill Covitrap Device Weredeveloped By Dr Trairak Pisitkun 39s Team From Chulalongkorn University , Hailand Genscript Has Supported The Team With Antibody Production And Characterization During Early Phase Of Research Contributed To Development Vaill Covitrap By Producing Gmp Grade Antibodies On Their Proprietary Rapid Manufacturing Platform From Chulalongkorn University ,